SEARCH

SEARCH BY CITATION

References

  • Algvere PV, Gouras P & Dafgård Kopp E (1999): Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 9: 217230.
  • Algvere PV, Libert C & Seregard S (2001): Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration. Semin Ophthalmol 16: 9096, in press.
  • Alm A & Bill A (1973): Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determination of brain and some other tissues. Exp Eye Res 15: 1529.
  • AREDS Report No. 8 (2001): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119: 14171436.
  • Au Eong KG, Pieramici DJ, Fujii GY et al. (2001): Macular translocation: unifying concepts, terminology, and classification. Am J Ophthalmol 131: 244253.
  • Barron MJ, Johnson MA, Andrews RM et al. (2001): Mitochondrial abnormalities in ageing macular photoreceptors. Invest Ophthalmol Vis Sci 42: 3063022.
  • Beatty S, Koh H-H, Phil M, Henson D & Boulton M (2000): The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 454: 115134.
  • Cao W, Tombran-Tink J, Elias R et al. (2001): In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 42: 16461652.
  • Choroidal Neovascularization Prevention Trial Research Group (1998): Laser treatment in eyes with large drusen. Ophthalmology 105: 1123.
  • Conolly BP, Regillo CD, Eagle RC et al. (2001): The histopathologic effects of transpupillary thermotherapy in human eyes. Invest Ophthalmol Vis Sci 42/4: S513.
  • Curcio CA, Medeiros NE & Millican CL (1996): Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 12361249.
  • Curcio CA & Millican CL (1999): Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 117: 329339.
  • Curcio CA, Millican CL, Bailey T & Kruth HS (2001): Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42: 265274.
  • Curcio CA, Owsley C & Jackson GR (2000): Spare rods, save the cones in ageing and age-related maculopathy. Invest Ophthalmol Vis Sci 41: 20152018.
  • Del Priore L, Newark NJ, Tezel TH, Kuo Y-H & Kaplan H (2000): The retinal pigment epithelium undergoes age-related apoptosis in human eyes. The Retina Society, USA, 33rd Annual Meeting, Coral Gables, Florida.
  • Delori FG, Goger DG & Dorey K (2001): Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42: 18551866.
  • Duke-Elder WS (1940): Textbook of Ophthalmology. Henry Kimpton, London. 21162372.
  • Eckardt C, Eckardt U & Conrad HG (1999): Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 237: 313325.DOI: 10.1007/s004170050239
  • Figueroa MS, Regueras A & Bertrand J (1994): Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 14: 391394.
  • Fine SL, Maguire MG, Javornik NB, Ho AC & CNVT Research Group (2001): The choroidal neovascularization prevention trial (CNVT): 4 year results. Invest Ophthalmol Vis Sci 42/4: S127.
  • Frennesson C & Nilsson SEG (1998): Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol 82: 11691174.
  • Ghazi NG, Jabbour NM, De la Cruz ZC & Green WR (2001): Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina 21: 478486.
  • Green WR, Enger C (1993): Age-related macular degeneration histopathological studies. The Lorenz E Zimmerman Lecture. Ophthalmology 100: 15191535.
  • Grimm C, Wenzel A, Williams TP et al. (2001): Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci 42: 497505.
  • Grunwald JE, Hariprasad SM, DuPont J et al. (1998): Foveal choroidal blood flow in age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 39: 385390.
  • Guyer DR, Martin DM, Klein M & Haller J (2001): Anti-VEGF therapy in patients with exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 42/4: S522.
  • Haller JA, Hartranft CD, Fujii Pieramici D, Humayan MS & De Juan E (2000): Limited macular translocation for neovascular maculopathy. Semin Ophthalmol 5: 8187.
  • Ham WT Jr, Ruffolo JJ Jr, Mueller HA et al. (1978): Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Invest Ophthalmol Vis Sci 17: 10291035.
  • Hinton DR, He S & Lopez PF (1998): Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol 116: 203209.
  • Holz FG, Schütt F, Kopitz J et al. (1999): Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 40: 737743.
  • International ARM Epidemiological Study Group (1995): An international classification and grading system for age-related maculopathy and macular degeneration. Surv Ophthalmol 39: 367374.
  • Jin G-F, Hurst JS & Godley BF (2001): Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res 23: 1119.
  • Kaplan HJ, Leibole MA, Tezel T & Ferguson TA (1999): Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 5: 292297.
  • Katz ML & Redmond TM (2001): Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 42: 30233030.
  • Klein R, Klein BEK & Linton KLP (1992): Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99: 933943.
  • Laatikainen L & Hirvelä H (1995): Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta Ophthalmol 73: 105110.
  • LaVail MM (1976): Survival of some photoreceptor cells in albino rats following long-term exposure to continuous light. Invest Ophthalmol 15: 6470.
  • Marcus DM, Sheils C, Johnson MH et al. (2001): External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration. Arch Ophthalmol 119: 171180.
  • McCarty CA, Mukesh BN, Fu CL et al. (2001): Risk factors for age-related maculopathy. Arch Ophthalmol 119: 14551462.
  • Medeiros NE & Curcio CA (2001): Preservation of ganglion cells layer neurons in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 795803.
  • Mitchell P, Smith W, Attebo K & Wang JJ (1995): Prevalence of age-related maculopathy in Australia: the Blue Mountain Eye Study. Ophthalmology 102: 14501460.
  • Mori K, Duh E, Gehlbach P et al. (2001): Pigment epithelium-derived growth factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188: 253263.
  • Newsom RSB, McAllister JC, Saeed M & McHugh JDA (2001): Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization. Br J Ophthalmol 85: 173178.
  • Ogata N, Tombran-Tink J, Jo N, Mrazek D & Matsumara M (2001): Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol 132: 427429.
  • Owsley C, Jackson GR, Cideciyan AV et al. (2000): Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 41: 267273.
  • Pauleikhoff D, Harper CA, Marshall J & Bird AC (1990): Ageing changes in Bruch's membrane. A histochemical and morphological study. Ophthalmology 97: 171178.
  • Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group (1999): A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology 106: 22392247.
  • Reichel E, Berrocal AM, Michael IP et al. (1999): Transpupillary thermotherapy of occult subfoveal neovascularization in patients with age-related macular degeneration. Ophthalmology 106: 19081914.
  • Sarks JP, Sarks SH & Killingsworth MC (1997): Morphology of early choroidal neovascularization in age-related macular degeneration. Eye 11: 515522.
  • Schütt F, Davies S, Kopitz J, Holz FG & Boulton ME (2000): Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 41: 23032308.
  • Shamsi FA & Boulton M (2001): Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 42: 30413046.
  • Smith W, Assink J, Klein R et al. (2001): Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 108: 697704.DOI: 10.1016/S0161-6420(00)00580-7
  • Snodderly DM, Auran JD & Delori FC (1984): The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25: 674685.
  • Sparrow JR & Cai B (2001): Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 42: 13561362.
  • Submacular Surgery Trials Pilot Study Investigators (2000): Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes. Am J Ophthalmol 130: 387407.
  • Sundelin SP, Nilsson SE & Brunk UT (2001): Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content. Free Radic Biol Med 30: 7481.
  • TAP Report No. 2 (2001): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin. Arch Ophthalmol 119: 198207.
  • Thumann G, Aisenbrey S, Schraermeyer U et al. (2000): Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol 118: 13501355.
  • Van Newkirk MR, Nanjan M, Wang JJ et al. (2000): The prevalence of age-related maculopathy. Ophthalmology 107: 15931600.
  • Verteporfin in Photodynamic Therapy Study Group (2001): Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization – Verteporfin in Photodynamic Therapy Report No. 2. Am J Ophthalmol 131: 541560.
  • Vinding T (1989): Age-related macular degeneration: macular changes, prevalence, and sex ratio: an epidemiological study of 1000 aged individuals. Acta Ophthalmol 67: 609616.
  • Vingerling JR, Dielemans I, Hofman A et al. (1995): The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 102: 205210.
  • Wenzel A, Grimm C, Seeliger M et al. (2001): Prevention of photoreceptor apoptosis by activation of the glucocorticoid factor. Invest Ophthalmol Vis Sci 42: 16531659.
  • Wu J, Seregard S, Spångberg B, Oskarsson M & Chen E (1999): Blue light induced apoptosis in rat retina. Eye 13: 577583.